Filing Details
- Accession Number:
- 0001179110-10-010953
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-06-24 13:00:00
- Reporting Period:
- 2010-06-22
- Filing Date:
- 2010-06-24
- Accepted Time:
- 2010-06-24 19:15:39
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1142596 | Nuvasive Inc | NUVA | Surgical & Medical Instruments & Apparatus (3841) | 330768598 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1289409 | Patrick Miles | 7475 Lusk Blvd. San Diego CA 92121 | President, Americas | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2010-06-22 | 2,500 | $23.24 | 5,308 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-22 | 2,500 | $38.45 | 2,808 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2010-06-22 | 2,924 | $23.24 | 5,732 | No | 4 | M | Direct | |
Common Stock | Disposition | 2010-06-22 | 2,924 | $39.63 | 2,808 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2010-06-22 | 5,424 | $0.00 | 5,424 | $23.24 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
57,312 | 2017-01-16 | No | 4 | M | Direct |
Footnotes
- The shares sold were acquired contemporaneously upon the cashless exercise of a stock option at an exercise price of $23.24 per share.
- The sale reported on this Form 4 was effected pursuant to a rule 10b5-1 trading plan adopted by the Reporting Person on May 19, 2009.
- 25% of the total shares subject to the option vested on January 16, 2008 which was the first anniversary of the date of grant; the remaining shares vest in 36 equal monthly installments thereafter.